Long non-coding RNA COL4A2-AS1 facilitates cell proliferation and glycolysis of colorectal cancer cells via miR-20b-5p/hypoxia inducible factor 1 alpha subunit axis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016 Mar-Apr;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017 Jan;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Brungs D, Aghmesheh M, de Souza P, et al. Safety and efficacy of oxaliplatin doublet adjuvant chemotherapy in elderly patients with stage III colon cancer. Clin Colorectal Cancer. 2018 Sep;17(3):e549–e555.
   PubMed Web of Science ®Google Scholar
• Li J, Li XL, Yuan Y, et al. Disputes and exploration of neoadjuvant and adjuvant therapy for colon cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):329–335.
   PubMedGoogle Scholar
• Tan X, Mao L, Huang C, et al. Comprehensive analysis of lncRNA-miRNA-mRNA regulatory networks for microbiota-mediated colorectal cancer associated with immune cell infiltration. Bioengineered. 2021 Dec;12(1):3410–3425.
   PubMed Web of Science ®Google Scholar
• Hua Q, Xu W, Shen X, et al. Dynamic changes of plasma extracellular vesicle long RNAs during perioperative period of colorectal cancer. Bioengineered. 2021 Dec;12(1):3699–3710.
   PubMed Web of Science ®Google Scholar
• Kogo R, Shimamura T, Mimori K, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011 Oct 15;71(20):6320–6326.
   PubMed Web of Science ®Google Scholar
• Niinuma T, Suzuki H, Nojima M, et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012 Mar 1;72(5):1126–1136.
   PubMed Web of Science ®Google Scholar
• Liu J, Qian J, Mo Q, et al. NR2F2-AS1 silencing induces cell cycle arrest in G0/G1 phase via downregulating cyclin D1 in colorectal cancer. Cancer Manag Res. 2020;12:1835–1843.
   PubMed Web of Science ®Google Scholar
• Ding Y, Feng W, Ge JK, et al. Serum level of long noncoding RNA B3GALT5-AS1 as a diagnostic biomarker of colorectal cancer. Future Oncol. 2020 Mar 24. DOI:10.2217/fon-2019-0820.
   Web of Science ®Google Scholar
• Yao Y, Zhang T, Qi L, et al. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer. J Cell Mol Med. 2019 Dec;23(12):8410–8419.
   PubMed Web of Science ®Google Scholar
• Murray LS, Lu Y, Taggart A, et al. Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. Hum Mol Genet. 2014 Jan 15;23(2):283–292.
   PubMed Web of Science ®Google Scholar
• Millen S, Gross C, Donhauser N, et al. (COL4A1, COL4A2), a component of the viral biofilm, is induced by the HTLV-1 oncoprotein tax and impacts virus transmission. Front Microbiol. 2019;10:2439.
   PubMed Web of Science ®Google Scholar
• Skovbjerg H, Anthonsen D, Lothe IM, et al. Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer. 2009 May 7;9:136.
   PubMed Web of Science ®Google Scholar
• JingSong H, Hong G, Yang J, et al. siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration. Oncotarget. 2017 Jan 10;8(2):2585–2593.
   PubMedGoogle Scholar
• Liu Y, Zhang J, Chen Y, et al. The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis. Aging (Albany NY). 2020 Jan 5;12(1):204–223.
   PubMedGoogle Scholar
• Brown CW, Brodsky AS, Freiman RN. Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2. Mol Cancer Res. 2015 Jan;13(1):78–85.
   PubMed Web of Science ®Google Scholar
• Gu C, Zou S, He C, et al. Long non-coding RNA CCAT1 promotes colorectal cancer cell migration, invasiveness and viability by upregulating VEGF via negative modulation of microRNA-218. Exp Ther Med. 2020 Apr;19(4):2543–2550.
   PubMed Web of Science ®Google Scholar
• Yang X, Tao H, Wang C, et al. lncRNA-ATB promotes stemness maintenance in colorectal cancer by regulating transcriptional activity of the beta-catenin pathway. Exp Ther Med. 2020 Apr;19(4):3097–3103.
   PubMed Web of Science ®Google Scholar
• Wang L, Cho KB, Li Y, et al. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 16 Nov 2019;20(22). DOI:10.3390/ijms20225758.
   Web of Science ®Google Scholar
• Nikolaou S, Qiu S, Fiorentino F, et al. Systematic review of blood diagnostic markers in colorectal cancer. Tech Coloproctol. 2018 Jul;22(7):481–498.
   PubMed Web of Science ®Google Scholar
• Zheng B, Jeong S, Zhu Y, et al. miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA). Oncotarget. 2017 Nov 21;8(59):100819–100830.
   PubMedGoogle Scholar
• Ding L, Lan Z, Xiong X, et al. The dual role of MicroRNAs in colorectal cancer progression. Int J Mol Sci. 2018 Sep 17;19.
   Web of Science ®Google Scholar
• Marmol I, Sanchez-de-diego C, Pradilla Dieste A, et al. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017 19;18:Jan.
   Web of Science ®Google Scholar
• Wang YQ, Jiang DM, Hu SS, et al. SATB2-AS1 suppresses colorectal carcinoma aggressiveness by inhibiting SATB2-dependent snail transcription and epithelial-mesenchymal transition. Cancer Res. 2019 Jul 15;79(14):3542–3556.
   PubMed Web of Science ®Google Scholar
• Zhuang M, Zhao S, Jiang Z, et al. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. EBioMedicine. 2019Mar;41:286–298.
   PubMed Web of Science ®Google Scholar
• Shi L, Hong X, Ba L, et al. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression. Cell Death Dis. 2019 Feb 15;10(3):150.
   PubMedGoogle Scholar
• Wen R, Chen C, Zhong X, et al. PAX6 upstream antisense RNA (PAUPAR) inhibits colorectal cancer progression through modulation of the microRNA (miR)-17-5p/zinc finger protein 750 (ZNF750) axis. Bioengineered. 2021 Dec;12(1):3886–3899.
   PubMed Web of Science ®Google Scholar
• Rao X, Huang X, Zhou Z, et al. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013 Aug;3(3):71–85.
   PubMedGoogle Scholar
• Warburg O. On the origin of cancer cells. Science (New York, NY). 1956 Feb 24;123(3191):309–314.
   Google Scholar
• Li X, Sun J, Xu Q, et al. Oxymatrine inhibits colorectal cancer metastasis via attenuating PKM2-mediated aerobic glycolysis. Cancer Manag Res. 2020;12:9503–9513.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Tang D, Yang Z, Long F, et al. Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer. Cell Signal. 2019May;57:21–28.
   PubMed Web of Science ®Google Scholar
• Tang D, Yang Z, Long F, et al. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis. J Cell Physiol. 2019 Nov;234(11):20816–20828.
   PubMed Web of Science ®Google Scholar
• Mullany LE, Herrick JS, Sakoda LC, et al. miRNA involvement in cell cycle regulation in colorectal cancer cases. Genes Cancer. 2018 Jan;9(1–2):53–65.
   PubMedGoogle Scholar
• Bruno T, Valerio M, Casadei L, et al. Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1alpha stabilization. J Exp Clin Cancer Res. 2017 Feb 18;36(1):32.
   PubMedGoogle Scholar
• Palazon A, Tyrakis PA, Macias D, et al. An HIF-1alpha/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell. 2017 Nov 13;32(5):669–683.e5.
   PubMed Web of Science ®Google Scholar
• Liu L, Ji P, Qu N, et al. The impact of high co-expression of Sp1 and HIF1alpha on prognosis of patients with hepatocellular cancer. Oncol Lett. 2016 Jul;12(1):504–512.
   PubMed Web of Science ®Google Scholar
• Zhang W, Tong D, Liu F, et al. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis. Oncotarget. 2016 Feb 2;7(5):5800–5814.
   PubMedGoogle Scholar
• Baba Y, Nosho K, Shima K, et al. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol. 2010 May;176(5):2292–2301.
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010 Feb;20(1):51–56.
   PubMed Web of Science ®Google Scholar
• Azoitei N, Becher A, Steinestel K, et al. PKM2 promotes tumor angiogenesis by regulating HIF-1alpha through NF-kappaB activation. Mol Cancer. 2016;15:3.
   PubMed Web of Science ®Google Scholar